Correction to "Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years".

IF 19.3 1区医学 Q1 PHARMACOLOGY & PHARMACY

Pharmacological Reviews Pub Date : 2023-12-15 DOI:10.1124/pharmrev.122.000600err

引用次数: 0

查看原文本刊更多论文

内源性大麻素系统作为治疗靶点的利弊：30 年后的经验教训"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacological Reviews 医学-药学

CiteScore

34.70

自引率

0.50%

发文量

期刊介绍： Pharmacological Reviews is a highly popular and well-received journal that has a long and rich history of success. It was first published in 1949 and is currently published bimonthly online by the American Society for Pharmacology and Experimental Therapeutics. The journal is indexed or abstracted by various databases, including Biological Abstracts, BIOSIS Previews Database, Biosciences Information Service, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus, Index to Scientific Reviews, Medical Documentation Service, Reference Update, Research Alerts, Science Citation Index, and SciSearch. Pharmacological Reviews offers comprehensive reviews of new pharmacological fields and is able to stay up-to-date with published content. Overall, it is highly regarded by scholars.